Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
=====Anti-CD20 [[Monoclonal Antibody]]===== | =====Anti-CD20 [[Monoclonal Antibody]]===== | ||
| - | * Arzerra - Generic: Ofatumumab | + | * [[Arzerra]] - Generic: Ofatumumab |
* Rituxan - Generic: Rituximab | * Rituxan - Generic: Rituximab | ||
* Zevalin - Generic: Ibritumomab | * Zevalin - Generic: Ibritumomab | ||
Revision as of 08:44, 14 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
